Elastin fragments drive disease progression in a murine model of emphysema by Houghton, A. McGarry et al.




Elastin fragments drive disease progression in a








Washington University School of Medicine in St. Louis
Diane G. Kelley
Washington University School of Medicine in St. Louis
See next page for additional authors
Follow this and additional works at: http://digitalcommons.wustl.edu/open_access_pubs
This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been accepted for inclusion in Open
Access Publications by an authorized administrator of Digital Commons@Becker. For more information, please contact engeszer@wustl.edu.
Recommended Citation
Houghton, A. McGarry; Quintero, Pablo A.; Perkins, David L.; Kobayashi, Dale K.; Kelley, Diane G.; Marconcini, Luiz A.; Mecham,
Robert P.; Senior, Robert M.; and Shapiro, Steven D., ,"Elastin fragments drive disease progression in a murine model of emphysema."
The Journal of Clinical Investigation.116,3. 753-759. (2006).
http://digitalcommons.wustl.edu/open_access_pubs/1535
Authors
A. McGarry Houghton, Pablo A. Quintero, David L. Perkins, Dale K. Kobayashi, Diane G. Kelley, Luiz A.
Marconcini, Robert P. Mecham, Robert M. Senior, and Steven D. Shapiro
This open access publication is available at Digital Commons@Becker: http://digitalcommons.wustl.edu/open_access_pubs/1535
3FTFBSDIBSUJDMF
 The Journal of Clinical Investigation   http://www.jci.org 
&MBTUJOGSBHNFOUTESJWFEJTFBTFQSPHSFTTJPO
JOBNVSJOFNPEFMPGFNQIZTFNB
A. McGarry Houghton,1 Pablo A. Quintero,1 David L. Perkins,2 Dale K. Kobayashi,3 Diane G. Kelley,3 
Luiz A. Marconcini,1 Robert P. Mecham,4 Robert M. Senior,3,4 and Steven D. Shapiro1
1Division of Pulmonary and Critical Care Medicine and 2Division of Nephrology, Brigham and Women’s Hospital, Harvard Medical School, Boston, 
Massachusetts, USA. 3Department of Medicine and 4Department of Cell Biology, Washington University School of Medicine, St. Louis, Missouri, USA.
Mice lacking macrophage elastase (matrix metalloproteinase-12, or MMP-12) were previously shown to be pro-
tected from the development of cigarette smoke–induced emphysema and from the accumulation of lung macro-
phages normally induced by chronic exposure to cigarette smoke. To determine the basis for macrophage accu-
mulation in experimental emphysema, we now show that bronchoalveolar lavage fluid from WT smoke-exposed 
animals contained chemotactic activity for monocytes in vitro that was absent in lavage fluid from macrophage 
elastase–deficient mice. Fractionation of the bronchoalveolar lavage fluid demonstrated the presence of elastin 
fragments only in the fractions containing chemotactic activity. An mAb against elastin fragments eliminated 
both the in vitro chemotactic activity and cigarette smoke–induced monocyte recruitment to the lung in vivo. 
Porcine pancreatic elastase was used to recruit monocytes to the lung and to generate emphysema. Elastin frag-
ment antagonism in this model abrogated both macrophage accumulation and airspace enlargement.
*OUSPEVDUJPO
Chronic obstructive pulmonary disease (COPD) currently affects 
over 18 million Americans and is the fourth leading cause of death 
in the US. The burden of this disease promises to increase through-
out the globe as smoking rates continue to climb in most devel-
oping countries (1). Emphysema, a major component of COPD, 
is characterized by an inflammatory cell infiltrate composed of 
alveolar macrophages, neutrophils, and CD4+ and CD8+ lympho-
cytes, and by the presence of proteinases in excess of their inhibi-
tors within the alveolar space, which leads to destruction and per-
manent enlargement of the peripheral airspaces of the lung (2–7). 
Macrophages are the predominant inflammatory cell type found 
in the lung both under normal conditions and in the setting of 
emphysema (8); however, the mechanisms responsible for the 
recruitment of peripheral blood monocytes to the lung in the set-
ting of emphysema remain poorly understood.
We have previously shown that mice deficient in macrophage 
elastase (matrix metalloproteinase-12, or MMP-12) are protect-
ed from cigarette smoke–induced emphysema (9). As expected, 
MMP-12+/+ mice displayed an increase in alveolar macrophage 
number in response to cigarette smoke when compared with 
non–smoke-exposed controls, but surprisingly, MMP-12–/– mice 
did not. This is not simply due to a requirement of MMP-12 for 
monocytes to properly emigrate from the vasculature to the lung 
because monocytes do not synthesize MMP-12; only differenti-
ated and activated tissue macrophages produce this proteinase 
(10). Consistent with this fact, monthly instillations of monocyte 
chemoattractant protein-1 (MCP-1), concomitant with cigarette 
smoke exposure, resulted in a significant increase in alveolar 
macrophages in the MMP-12–/– mice (although they were still pro-
tected from the development of emphysema). Thus, MMP-12–/– 
monocytes are capable of emigrating to the lung if the appropri-
ate stimulus is present.
In addition to C-C chemokine–producing cells, the lung possess-
es other potential monocyte chemotactic factors that reside within 
the ECM. Fragments of collagen (11), fibronectin (12), laminin 
(13), and elastin (14–16) have all been shown to be chemotactic 
for monocytes in vitro, but data to support a role for these agents 
in vivo are lacking. In the current study, we show that MMP-12 is 
required to generate the monocyte chemotactic activity present in 
a model of cigarette smoke–induced emphysema in the mouse and 
that elastin fragments (EFs) are required for macrophage accumu-
lation and airspace pathology in this setting.
3FTVMUT
Bronchoalveolar lavage fluid from MMP-12+/+ but not MMP-12–/– smoke-
exposed mice contains monocyte chemotactic activity. Bronchoalveolar 
lavage fluid (BALF) from WT smoke-exposed mice elicited a 5-fold 
increase in monocyte chemotaxis in vitro compared with BALF 
from control mice. In contrast, there was no chemotactic activity 
in BALF from MMP-12–/– smoke-exposed mice above that seen in 
non–smoke-exposed controls (Figure 1A). Of note, MMP-12 itself 
was not chemotactic for monocytes in our assay (not shown). Ini-
tially, we assayed for C-C chemokines, substances well known for 
their monocyte chemotactic properties. Real-time PCR was per-
formed on lung RNA from WT mice exposed to smoke for 1, 3, 
and 6 months, using primers for IL-1β, MCP-1, MCP-2, MIP-1α, 
MIP-1β, and RANTES (data not shown). There was no significant 
increase in RNA expression for any of these chemokines.
Having excluded the common chemokines, we began to search for 
a novel factor that is generated in MMP-12+/+ but not MMP-12–/– mice 
in the setting of cigarette smoke exposure. BALF from MMP-12+/+ 
and MMP-12–/– smoke-exposed mice was subjected to gel filtration 
chromatography. Chemotactic activity was identified only in the 
BALF from MMP-12+/+ mice, in fractions corresponding to a molecu-
lar mass of approximately 45 kDa. Significant chemotactic activity 
was not present in any fraction of MMP-12–/– BALF (Figure 1B).
Nonstandard abbreviations used: BAL, bronchoalveolar lavage; BALF, BAL fluid; 
CL, chord length; COPD, chronic obstructive pulmonary disease; EF, elastin frag-
ment; i.t., intratracheal(ly); MCP, monocyte chemoattractant protein; MMP-12,  
macrophage elastase (matrix metalloproteinase-12); NE, neutrophil elastase; PPE, 
porcine pancreatic elastase.
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EFs are the chemotactic factor present in BALF. Fractions of the BALF 
demonstrating chemotactic activity for monocytes in vitro were 
subjected to Western blot analysis using a panel of antibodies 
against putative chemokine components of the ECM, including 
thrombospondin, laminin, collagen, fibronectin, and elastin. Only 
antibodies directed against elastin were detected in chemotactic 
fractions (Figure 1C).
Additional in vitro assays of monocyte chemotaxis were per-
formed using lung homogenates from MMP-12+/+ and MMP-12–/– 
smoke-exposed animals and non–smoke-exposed controls. Con-
sistent with the results from the experiments using BALF as the 
chemoattractant, only the lung homogenates from MMP-12+/+ 
mice were chemotactic for monocytes. The lung homogenate dem-
onstrated significantly more potent (5-fold higher) chemotactic 
activity than the corresponding BALF. To show that EFs are the 
chemotactic factor present in MMP-12+/+ smoke-exposed BALF 
and lung homogenate, we repeated the monocyte chemotaxis 
assays with the addition of BA4 mAb (50 nM) to the lower com-
partments. BA4, an mAb that was derived from an immunization 
with the α-elastin fraction of insoluble elastin, completely elimi-
nated the activity present in BALF and lung homogenate (Figure 
1D). However, BA4 had no effect on formyl-Met-Leu-Phe–induced 
(fMLP-induced) chemotaxis (not shown).
EF inhibition decreases cigarette smoke–induced lung macrophage accu-
mulation in vivo. To illustrate that EFs influence cigarette smoke–
induced lung macrophage accumulation in vivo, we used a 1-week 
cigarette smoke exposure protocol. Acute cigarette smoke exposure 
experiments are certainly too brief to produce airspace disease or 
emphysema, but they have been demonstrated to reliably produce 
an inflammatory cell infiltrate (17, 18). Using this protocol, we 
found that the monocyte recruitment elicited by the chemotactic 
factors generated by cigarette smoke exposure in vivo can be inhib-
ited 66% by BA4 (P = 0.0005) (Figure 2).
EFs are chemotactic for monocytes in vivo. To further prove that EFs 
are capable of recruiting peripheral blood monocytes to the lung 
in vivo, we administered purified EFs (no residual elastase in the 
digest) intratracheally (i.t.) to WT mice. Intratracheal instillation 
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content both in the BALF and in the lung parenchyma by 72 hours 
(Table 1). Specifically, EFs, at doses of 10 μg and 100 μg, increased 
the number of lung macrophages by 65% and 117%, respective-
ly, compared with PBS-treated controls (P < 0.01). Intratracheal 
administration of VGVAPG, a frequently repeated sequence in 
tropoelastin that is well known for its chemotactic properties, 
produced a 73% increase in lung macrophage content at 72 hours 
 (P < 0.01) (Table 1). Furthermore, i.t. administration of the approx-
imately 45-kDa EFs produced a significant increase in lung macro-
phage content at 72 hours (Table 1). EFs did not recruit neutro-
phils to the alveolar space above the level seen in controls.
Porcine pancreatic elastase is capable of recruiting monocytes to the lung 
in vivo. Despite widespread use over the past 30 years, the exact 
nature of the inflammatory component present in the porcine 
pancreatic elastase (PPE) model of emphysema has yet to be fully 
characterized. To prove that PPE generates an inflammatory cell 
infiltrate, we instilled PPE i.t. and quantified the number of mac-
rophages and neutrophils present in the BALF 1, 3, 7, 14, and 21 
days later (Figure 3). A single i.t. dose of PPE (1 U = 7.4 μg) pro-
duced a significant increase in BALF macrophages (Figure 3A) and 
neutrophils (Figure 3B) that peaked at 7 and 3 days, respectively. 
The increase in lung macrophages was also evident in the lung 
parenchyma on mac-3–stained sections (Figure 3C). Because PPE 
generates airspace disease, the chord length (CL) was determined 
so that the cell counts could be corrected for tissue density.
EF antagonism reduces PPE-induced accumulation of 
alveolar macrophages in vivo. We used the PPE model of 
emphysema to study the role of EFs in the recruitment 
of peripheral blood monocytes to the lung in the setting 
of experimental emphysema. Intratracheal PPE is well 
known to induce airspace enlargement, generate EFs, 
and, as we have shown here, increase lung macrophage 
content. We administered BA4 i.t. to elastase-recipient 
mice over either 3 or 21 days, using antibodies against 
collagen and laminin and an IgG1 isotype antibody as 
controls. Treatment with BA4 resulted in 62% and 91% 
reduction in lung macrophage content adjusted for 
alveolar tissue density on mac-3–stained sections at the 
3-day and 21-day time points, respectively, when com-
pared with IgG1 isotype control (P < 0.001) (Figure 3, 
D–G). Collagen and laminin antibodies had no effect on macro-
phage accumulation in this setting.
EF antagonism abrogates PPE-induced emphysema. Pancreatic elastase 
causes a direct proteolytic injury to the lung that results in a small 
increase in airspace size before it is rapidly cleared. The majority of 
the airspace enlargement present after 21 days (∼80%) is the result 
of the chronic inflammatory process initiated by PPE (19). There-
fore, modification of this inflammatory process could result in a 
reduction in the amount of PPE-induced emphysema. To show the 
5BCMF
Intratracheal instillation of PBS, EFs, and PPE
 Macrophages/ BAL macrophages BAL PMNs
 mm alveolar wall  (104)  (104)
PBS 1.74 ± 0.06 10.24 ± 1.02 0
PPE (1 U) 3.99 ± 0.35A 18.48 ± 1.79A 1.75 ± 0.26A
EF peptides (10 μg) 2.88 ± 0.13A 19.85 ± 0.75A 0
EF peptides (100 μg) 3.77 ± 0.22A 19.63 ± 2.95A 0.07 ± 0.06
VGVAPG (5 μg) 3.01 ± 0.13A – –
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dependence of macrophage accumulation and airspace enlarge-
ment on the presence of EFs, we repeatedly administered BA4 or 
isotype control antibody i.t. to PPE-recipient mice and measured 
the airspace dimensions (CL) and alveolar tissue and airspace areas 
after 21 days. An additional control group received PBS only at 
each instillation. BA4 treatment resulted in complete protection 
from the development of emphysema, with the CL being the same 
as that in PPE-treated mice after 24 hours, or the part of the injury 
that is the result of direct proteolysis (Figure 4).
%JTDVTTJPO
Accumulation of macrophages in the interstitium, septum, and 
alveolar airspace of the lung is one of the characteristic features of 
pulmonary emphysema. Over 20 years ago, 2 separate reports by 
Hunninghake et al. and by members of our group (R.M. Senior and 
R.P. Mecham) demonstrated that EFs possessed chemotactic prop-
erties for monocytes in vitro, but, notably, not for mature alveolar 
macrophages or neutrophils (14–16). That work fueled specula-
tion that EFs may play a role in the recruitment of monocytes 
to the lung in emphysema, given that the lung represents a sig-
nificant source of elastin. Although mature, cross-linked elastic 
fibers are not chemotactic, cryptic sequences of the protein may be 
released within the ECM upon proteolysis by elastolytic enzymes, 
such as MMP-12 or neutrophil elastase (NE). Despite these well-
characterized chemotactic properties for monocytes in vitro, a role 
for EFs in vivo in general, and in the pathogenesis of emphysema 
in particular, has remained purely speculative. Moreover, with the 
discovery of the large C-C chemokine family, the role of matrix 
fragments in mediating chemotaxis seemed minimal, at best.
We entertained a number of potential mechanisms that could 
explain the discrepancy that we observed in lung macrophage con-
tent between WT and MMP-12–/– smoke-exposed mice. We have 
previously shown that MMP-12–/– peripheral blood monocytes are 
capable of emigrating to the lung when an appropriate stimulus is 
provided (9). Bone marrow transplantation was 
used to demonstrate that the half-lives of WT 
and MMP-12–/– lung macrophages are equivalent 
(both are 18 days) and that resident alveolar mac-
rophages do not proliferate, confirming that the 
accumulation of lung macrophages in our model 
was due to recruitment of new blood monocytes 
to the lung and not due to local clonal expansion 
of resident lung macrophages (data not shown).
The finding that BALF from MMP-12+/+, but 
not from MMP-12–/–, mice contained monocyte chemotactic 
activity led us to search initially for known, and later for novel, 
chemotactic factors that were generated only in the MMP-12+/+ 
mice. We were able to detect only fragments of elastin, a known 
substrate for MMP-12 (20), in chemotactic fractions of bronchoal-
veolar lavage (BAL). Inhibition of monocyte chemotaxis using BA4 
confirmed the dependence of this chemotactic activity on EFs. EF 
inhibition is relevant in vivo as well, given that BA4 administration 
concomitant with cigarette smoke exposure significantly reduced 
the accumulation of lung macrophages.
To demonstrate that EF-driven macrophage accumulation can 
inhibit the development of emphysema, we turned to the PPE 
model of emphysema. The PPE model, used to reliably generate 
experimental emphysema for decades, has been criticized in the 
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destruction of the alveolar wall, and thus having little in common 
with the chronic, low-grade inflammation observed in emphyse-
ma. However, recent data suggest that the amount of emphysema 
generated by direct proteolytic tissue destruction by PPE is mini-
mal, compared with the lesion that develops over the ensuing 3–4 
weeks related to endogenous inflammation and destruction. Mod-
ification of this inflammatory cascade has been demonstrated to 
significantly reduce the resultant airspace disease (19), suggesting 
that PPE generates a chronic inflammatory condition that more 
closely resembles that of human emphysema than was previously 
thought. We used the PPE model of emphysema here to show that 
EF inhibition over a 3-week time course significantly decreases the 
accumulation of lung macrophages and eliminates the develop-
ment of airspace pathology, with the amount of airspace disease 
present in the BA4 group being similar to that present 24 hours 
after the administration of PPE, or the part of the injury that is the 
direct result of PPE-mediated proteolysis. EF antagonism reduced 
PPE-induced lung macrophage accumulation by 65% and 90% at 
3 and 21 days, respectively. Prolonged treatment with BA4, there-
fore, achieves a more complete reduction in macrophage number, 
but there certainly exists an alternative mechanism that would 
account for the remainder. We have not been unable to detect 
significant increases in the C-C chemokines, so there is likely an 
alternate, as-yet unrecognized chemotactic factor.
EFs exert their chemotactic influence on monocytes via inter-
action with the elastin-binding protein (EBP) (21). Whereas the 
hexapeptide VGVAPG, a commonly repeated sequence in human 
elastin, is the most well-recognized ligand for this receptor, 
numerous other EFs are capable of binding to the EBP. In addi-
tion to VGVAPG, all elastin-derived peptides that follow the motif 
GXXPG or XGXPG (where X is a hydrophobic amino acid) display 
chemotaxis for monocytes in vitro (22, 23). This is noteworthy 
because the murine tropoelastin sequence does not contain the 
VGVAPG sequence; however, it does contain significant quantities 
of both GXXPG and XGXPG. In fact, these commonly repeated 
sequences represent 21% of the entire mouse tropoelastin sequence. 
Also of note, epitope recognition studies have demonstrated that 
BA4 also binds to all peptides that follow the GXXPG and XGXPG 
motifs (24), thus explaining why it is an effective inhibitor of the 
chemotactic EFs generated in the mouse. Although the monocyte 
chemotactic properties of EFs reside within these hydrophobic 
penta- and hexapeptide repeats, the EFs generated in vivo tend 
to be much larger. In the current study, we identified EFs in the 
BALF from WT smoke-exposed mice in gel filtration fractions of 
approximately 45 kDa (the broad peak of activity ranged from 35 
to 50 kDa). Prior studies have demonstrated a wide range in the 
size of EFs that possess monocyte chemotactic activity, from 10 to 
50 kDa, that seems to depend on the type of elastin digested and 
the enzyme used to digest it (14–16).
Mature elastin is a complex polymer of tropoelastin monomers 
that have been irreversibly cross-linked by the enzyme lysyl oxi-
dase. As a result, the mature protein is highly insoluble, and frag-
ments generated from the polymer by proteolysis (Figure 5) are 
heterogeneous in size and composition (the broad band detected 
here is likely the result of several distinct fragments between 35 
and 50 kDa, not 1 unique EF). Most contain multiple chain frag-
ments joined through 1 or more cross-links, making their charac-
terization by conventional proteomic approaches difficult if not 
impossible (25). Given the extensive prior work showing that the 
chemotactic properties of EFs reside within the commonly repeat-
ed penta- and hexapeptides, and that BA4 effectively inhibits them 
both in vitro and in vivo, it is likely that the larger peptides we iden-
tified contain the chemotactic sequences cross-linked with other 
regions of the protein. Furthermore, additional analysis of sub-
strate specificities for MMP-12, within elastin, may provide insight 
into the unique structural features of EFs generated in vivo.
Based on our previous findings and our current study of 
MMP-12–/– mice, we hypothesize that alveolar macrophages become 
activated upon chronic exposure to cigarette smoke; that these 
macrophages release MMP-12 that degrades ECM components 
including elastin; and that the degradation of elastin results in 
the generation of EFs chemotactic for monocytes. The early influx 
of neutrophils and NE caused by cigarette smoke exposure (17, 
18) also contributes to the generation of EFs and provides a pos-
sible explanation as to why NE–/– mice are partially protected from 
both the accumulation of macrophages and the development of 
airspace enlargement upon exposure to cigarette smoke (26). The 
interplay between macrophages and neutrophils in this process is 
unlikely to be limited to the generation of EFs. We have previously 
shown that NE is capable of degrading the tissue inhibitors of 
metalloproteinases (TIMPs), the major inhibitors of MMP-12. Fur-
thermore, MMP-12 degrades α1-antitrypsin, whose major func-
tion is to inhibit NE. Thus it appears that these proteinases are 
able to indirectly augment each other’s function by degrading one 
another’s inhibitors. However, it is not surprising that the lack of 
MMP-12 would prevent the generation of cigarette smoke–induced 
EFs in our model, given that the recruitment of neutrophils (and 
NE) by cigarette smoke in mice is modest, when compared with 
macrophage accumulation. Therefore, given the sparse repre-
sentation of neutrophils in the cigarette smoke–induced emphy-
sema in our mice that are housed in a sterile barrier facility, the 
greater relative importance of the macrophage and its degrada-
tive enzymes is not surprising. Whereas PPE administration elicits 
both macrophage and neutrophil inflammation (Figure 3), the 
neutrophils are cleared rapidly in this setting, apparently leaving 
the majority of alveolar tissue destruction to macrophages, which 
maintain their upregulation, presumably via continued produc-
tion of EFs. It is also possible that EFs induce MMP biosynthesis 
(27). This EF chemotactic signal ultimately leads to enhanced lung 
tissue destruction by placing more macrophages, and thus more 
MMP-12, within close proximity of the airspace. In the absence of 
repair, peripheral airspace enlargement is the result (28).
Although the findings here are limited to a model of emphy-
sema, the concept that degradation products of elastin can drive a 
macrophage-predominant, chronic inflammatory disease process 
is potentially applicable to all diseases that occur in elastin-rich 
organs, including coronary artery disease, peripheral vascular dis-
ease, and aortic aneurysm (29). Additionally, EF antagonism rep-
resents a potential therapeutic strategy for COPD, a disease for 
which, to date, there are no available disease-modifying agents.
.FUIPET
Materials. All reagents were obtained from Sigma-Aldrich unless otherwise 
noted. BA4 is a mouse anti-bovine IgG1-subclass mAb that was derived 
from an immunization with the α-elastin fraction of insoluble elastin. It 
has subsequently been shown to recognize the VGVAPG hexapeptide found 
in human elastin, among others (24).
Mice. MMP-12–deficient mice and WT littermates were used for the exper-
iments involving cigarette smoke exposure. The MMP-12–/– mice were gen-
erated in our laboratory as previously described (10). Briefly, intron 1 and 
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exon 2 were disrupted by the insertion of the phosphoglycerolkinase pro-
moter and neomycin resistance genes (PGK-neo). The construct was electro-
porated into RW4 ES cells, and correctly targeted clones were microinjected 
into C57BL/6J blastocysts. Mice homozygous for the MMP-12 mutation 
were backcrossed 10 generations into the C57BL/6J background. Age- and 
sex-matched WT littermates were used as controls. All other experiments 
were carried out in C57BL/6J mice purchased from Jackson Laboratory. The 
Harvard Standing Committee for Animal Research at Harvard University 
School of Public Health approved all animal experiments.
Cigarette smoke exposure. MMP-12+/+ and MMP-12–/– mice (n = 10) were 
exposed to cigarette smoke from 2 unfiltered cigarettes (University of Ken-
tucky) 6 days a week for 1, 2, 3, or 6 months (depending on the experiment) 
using a smoking apparatus as previously described (9). The animals tolerated 
the treatment without evidence of toxicity (carboxyhemoglobin levels ∼10%). 
We additionally used an acute cigarette smoke exposure protocol in which 
the mice were subjected to the smoke from 4 cigarettes a day for 7 days.
BALF analysis. At the conclusion of a given experiment, mice were sacri-
ficed before performance of BAL via a 22-gauge i.v. catheter inserted into 
the trachea. The lungs were lavaged with 1 ml DMEM 3 times to obtain the 
BALF. The BALF was then centrifuged at maximum speed for 3 minutes, 
and the supernatant was retained for further analysis. BALF obtained in 
this way was subjected to gel filtration using an HPLC machine (Waters 
Corp.) with a HiLoad Superdex 200 column (Amersham Biosciences). Each 
BAL sample was loaded in a volume of 1 ml into a bed volume of 320 ml. 
Fractions were collected in 1-ml aliquots using a flow rate of 1 ml/min in a 
buffer composed of 50 mM Tris (pH 7.5), 10 mM CaCl2, and 150 mM NaCl. 
Using this technique, the BALF was separated into 56 fractions based on 
molecular weight. Each of the fractions was assayed for chemotactic prop-
erties as described below. Representative fractions (nos. 11 and 37) of the 
BALF (100× concentration) were then subjected to Western blot analysis 
using enhanced chemiluminescence. Polyclonal anti-elastin (rabbit anti-
mouse) antibody at a 1:1,000 dilution was used for Western blot analysis. 
BA4 mAb (described above) at a 1:1,000 dilution was used to confirm these 
results. In addition, the BALF was analyzed for cellular content. The BALF 
was centrifuged at 1,900 g for 3 minutes, the rbcs were lysed, and the BAL 
was resuspended in 1.0 ml normal saline. Macrophage, neutrophil, and 
total cell counts were determined using a hemocytometer and cytospins 
stained with HEMA 3 (Biochemical Sciences Inc.).
Mouse lung elastin was digested using human leukocyte elastase (both 
Elastin Products Co.) and subjected to gel filtration in a protocol similar 
to that described above. The fraction corresponding to a molecular weight 
of approximately 45 kDa was administered i.t. (see below) to demonstrate 
its monocyte chemotactic properties in vivo. Tris buffer control was not 
significantly different from PBS control (not shown).
Monocyte chemotaxis. Assays of monocyte chemotaxis were performed on 
human peripheral blood monocytes using either BALF or lung homogenate 
from WT and MMP-12–/– smoke-exposed and non–smoke-exposed control 
mice as the chemoattractants in separate experiments. Human peripheral 
blood monocytes were obtained by phlebotomy and purified using an elu-
triation centrifugation protocol. Monocytes were placed in the top wells of 
a microchemotaxis chamber at a concentration of 1.0 × 105 cells per well 
in DMEM. Depending on the assay, the lower compartments contained 
either (a) MMP-12+/+ versus MMP-12–/– unfractionated BALF from smoke-
exposed and non–smoke-exposed control mice normalized to total protein 
content of 2 mg/ml; (b) MMP-12+/+ versus MMP-12–/– BALF fraction (nos. 
1–56) from smoke-exposed and non–smoke-exposed controls normalized 
to total protein content of 8 μg/ml; or (c) MMP-12+/+ versus MMP-12–/– lung 
homogenate from smoke-exposed and non–smoke-exposed control mice. 
The chemotaxis assays using unfractionated BALF and lung homogenates 
were repeated with the addition of 50 nM BA4 to the lower compartment 
at the initiation of the experiment. Results are from a representative experi-
ment performed in triplicate.
Real-time PCR. WT mice (n = 6) were exposed to cigarette smoke as described 
above for 1, 3, or 6 months. Age- and sex-matched WT mice were used as 
non–smoke-exposed controls. The lungs were removed and frozen at –80°C. 
The lungs were homogenized in 1 ml cold TRIzol prior to RNA isolation 
according to the manufacturer’s instructions. After treatment with DNase I 
(Ambion Inc.) to remove contaminating DNA, the samples were reverse-
transcribed using RT-PCR beads with Poly(dT) oligonucleotides according 
to the manufacturer’s instructions (Amersham Biosciences). Real-time PCR 
analysis was performed using the GeneAmp 5700 Sequence Detection Sys-
tem (Applied Biosystems). The comparative CT method was employed using 
GAPDH as an endogenous reference housekeeping gene. Serial dilutions of 
a control sample of cDNA were used as the standard curve for each reac-
tion. SYBR Green buffer (Applied Biosystems) was used as the fluorophore. 
All experiments were performed in triplicate. The primer sequences were as 
follows: IL-1β, forward primer, 5′-CCTCTGGTGTGTGACGTTC-3′; reverse 
primer, 5′-TCTCGGAGCCTGTAGTGCAGT-3′; MCP-1, forward primer, 5′-
TTCTGGGCCTGCTGTTCAC-3′; reverse primer, 5′-GAGCCAACACGTG-
GATGCT-3′; MCP-2, forward primer, 5′-TCTCCCCTAATCTTCTCCAGG-
3′; reverse primer, 5′-CAGGCACCATCTGCTTGTAAC-3′; MIP-1α, forward 
primer, 5′-CTGCCTGCTGCTTCTCCTACA-3′; reverse primer, 5′-CAAC-
GATGAATTGGCGTGG-3′; MIP-1β, forward primer, 5′-TCTCTCCTCTT-
GCTCGTGGC-3′; reverse primer, 5′-TGGTGCTGAGAACCCTGGA-3′; 
RANTES, forward primer, 5′-GCAAGTGCTCCAATCTTGCA-3′; reverse 
primer, 5′-CTTGGCGGTTCCTTCGAGT-3′. Results are expressed as the 
fold change from non–smoke-exposed controls.
Intratracheal administration of EFs, PPE, and BA4. WT mice were anesthe-
tized with an i.p. injection of 2.5% Avertin. After the mice were appropriate-
ly sedated, they were intubated via direct visualization of the larynx using 
a 22-gauge i.v. catheter in which the needle point had been filed down to 
a blunt end and was used as a stylet. One unit (7.4 μg) PPE; 10 μg or 100 
μg purified digested bovine ligament elastin (i.e., EFs); 5 μg VGVAPG (all 
from Elastin Products Co.); the approximately 45-kDa EF (generated as 
described above); or PBS or Tris buffer control (n = 4–6 for each group) was 
administered i.t. in a total volume of 40 μl.
To demonstrate the dependence of monocyte recruitment to the lung 
on EFs in the PPE model of emphysema, we administered BA4 to inhibit 
the chemotactic properties of EFs. On day 1, WT mice were anesthetized 
with 2.5% Avertin and received a dose of 10 μg BA4 (n = 9), 10 μg IgG1 
isotype control antibody (n = 8), 10 μg anti–collagen type I antibody (Cal-
biochem) (n = 4), or 10 μg anti–laminin-5 antibody (R&D Systems) (n = 4) 
i.t. as described above. Two hours later, all of the animals received a single 
i.t. dose of PPE (1.0 U). On days 2 and 3, the mice again received i.t. doses of 
BA4 or isotype control. The animals were sacrificed after 72 hours.
To evaluate the effects of EF inhibition on the progression of airspace 
disease, we coadministered BA4 or IgG1 isotype control antibody i.t. to 
PPE-recipient mice. In this experiment, mice received a single dose of i.t. 
PPE (1.0 U) at time 0 and then received BA4 or control antibody on days 1, 
2, 3, 5, 7, 10, 13, 16, and 19. The animals were sacrificed on the 21st day.
In a separate experiment, mice received either i.t. BA4 or IgG1 isotype 
control concurrent with an acute cigarette smoke exposure protocol 
(described above).
Lung tissue preparation. At the conclusion of each experiment, the lungs 
were inflated to allow for further analysis. The animals were sacrificed at 
the appropriate time point, the RV was perfused with normal saline to 
remove blood, and the lungs were inflated at 25 cm H2O with 10% buffered 
formalin for 10 minutes via an i.t. catheter. The lungs were then removed 
and fixed for 24 hours before embedding in paraffin. Serial mid-sagittal 
sections were obtained for morphological and histological analysis.
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In addition, lung tissue homogenates were prepared from mice exposed 
to smoke for 2 months, by homogenization of the lungs in 5 ml of 50 mM 
Tris, 150 mM NaCl, and 10 mM CaCl2 buffer.
Morphometry. Mid-sagittal sections stained with a modified Gill’s stain were 
used to calculate the CL as previously described (9). Ten randomly selected 
×200 fields per slide were photographed using MetaMorph (Molecular 
Devices). The images were analyzed using Scion Image (Scion Corp.). Airway 
and vascular structures were eliminated from the analysis. The images were 
manually thresholded. The CLs were determined in both a horizontal and a 
vertical plane, allowing for the calculation of alveolar airspace areas.
Immunohistochemistry. Alveolar, interstitial, and septal macrophages 
were quantified with mac-3 immunostaining (rat anti-mouse antibody 
at 1:1,000 dilution; BD Biosciences — Pharmingen) on mid-sagittal sec-
tions using the avidin-biotin HRP technique in which 3,3′-diaminoben-
zidine was the chromogenic substrate. Results are represented as the 
average count from 5 different high-powered fields per slide that have 
been corrected for millimeters of alveolar wall using the morphometric 
data (as described above).
Statistics. Data are expressed as the mean value ± SEM unless otherwise 
indicated. Statistical significance was determined using the Student’s t test 
(2-tailed distribution with a 2-sample equal variance). P values less than 
0.05 were considered statistically significant.
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